Biogen Inc. buy Jefferies Financial Group Inc.
Start price
25.09.25
/
50%
€116.25
Target price
25.09.26
€161.80
Performance (%)
27.57%
Price
23.12.25
€148.30
Summary
This prediction is currently active. The prediction currently has a performance of 27.57%. This prediction currently runs until 25.09.26. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -0.603% | -0.603% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by Jefferies_Financial_ for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $190.00 price target on the stock.
Ratings data for BIIB provided by MarketBeat